Year archive

OXYGENTA PHARMACEUTICAL LIMITED — 2026 filings

All 5 regulatory filings released by OXYGENTA PHARMACEUTICAL LIMITED (524636) in 2026, sourced directly from the official regulator.

5 Filings

2026 Period

2026 filings (5)

Filing	Released	Lang
Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations, 2018. Regulatory Filings	2026-05-26	English
Change in Management by way of appointment of Additional Directors and Internal Auditor. Interim / Quarterly Report FY 2026	2026-05-23	English
Audited Financial Results for the Quarter and Year ended 31.03.2026. Regulatory Filings	2026-05-23	English
Outcome of the Board meeting held on 23rd May, 2026. Interim / Quarterly Report FY 2026	2026-05-23	English
Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve 1. Audited Financial .... Regulatory Filings	2026-05-19	English